相关实验视频
Updated: Jul 6, 2025

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
1.7K
组合的低分离放射治疗和 pembrolizumab 在无塑性甲状腺癌的甲状腺癌
Janice Ser Huey Tan1, Timothy Kwang Yong Tay2, Enya Hui Wen Ong3
1J Tan, Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore.
European thyroid journal
|January 5, 2024
概括
这项研究探讨了将免疫疗法 (pembrolizumab) 与辐射疗法 (QUAD-shot RT) 结合起来,用于治疗无塑性甲状腺癌 (ATC). 治疗显示出有希望的反应率,并且耐受性良好,这表明ATC患者的长期存活潜力.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 辐射瘤学 辐射瘤学
背景情况:
- 无塑性甲状腺癌 (ATC) 是高度侵略性的,预后不佳.
- 现有的ATC疗法有效性有限,并且与治疗耐药性有关.
研究的目的:
- 评估pembrolizumab免疫疗法和低分离放射疗法 (QUAD-shot RT) 的联合疗法的疗效和安全性.
- 评估响应者对这种组合治疗的免疫反应.
主要方法:
- 一个由5名ATC患者组成的病例系列接受了QUAD-shotRT和pembrolizumab.
- 布罗利祖马布每3-4周服用一次,直到进展或24个月.
- 循环T细胞的免疫分析在一个受试者中进行.
主要成果:
- 随访时间中位数为32.6个月,在5名患者中观察到80%的整体应答率 (2CR,2PR).
- 两个完全响应者仍然没有疾病.
- 无进展生存时间的中位数为7.6个月;一年的PFS和OS率为40%.
结论:
- QUAD-shot RT和pembrolizumab的组合在高级ATC中表现出显著的活性.
- 两名患者实现了长期存活,这表明局部和全身治疗的潜在协同效应.
- 这种治疗方案需要在更大的患者队列中进行进一步的研究.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K

